| Literature DB >> 23304015 |
Abstract
Extreme thrombocytosis is a major risk factor for excessive bleeding and for thrombosis, either of which can complicate cardiovascular surgical and interventional procedures. Extreme thrombocytosis can also cause an unusual syndrome, erythromelalgia, that results in a type of chronic microvascular occlusive arterial disease. We present the differential diagnosis of conditions that may lead to extreme thrombocytosis, 3 cases (each of which illustrates a different potential complication), and a review of the pertinent medical literature. Correcting excessive thrombocytosis is typically not difficult, whether electively or acutely, and effective therapy usually controls thrombosis and excessive hemorrhage post-procedurally.Entities:
Keywords: Coronary thrombosis/prevention & control/surgery; erythromelalgia; hemorrhage/drug therapy; hydroxyurea/therapeutic use; myeloproliferative disorders/genetics/pathology; plateletpheresis; polycythemia vera/blood; preoperative care/methods; risk factors; thrombocythemia, essential/complications/diagnosis/etiology/genetics/metabolism/physiopathology
Mesh:
Substances:
Year: 2012 PMID: 23304015 PMCID: PMC3528235
Source DB: PubMed Journal: Tex Heart Inst J ISSN: 0730-2347